carbamazepine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this patient with chronic lymphocytic leukemia, carbamazepine therapy had a significant and reproducible lymphopenic effect that was readily reversible upon discontinuation of the drug." | 1.29 | Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemia. ( Chapron, DJ; Silverman, DA, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silverman, DA | 1 |
| Chapron, DJ | 1 |
1 other study available for carbamazepine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemia.
Topics: Aged; Anticonvulsants; Carbamazepine; Female; Granulocytes; Humans; Leukemia, Lymphocytic, Chronic, | 1995 |